Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pilocarpine - ADVANZ Pharma

Drug Profile

Pilocarpine - ADVANZ Pharma

Alternative Names: KSS-694; Salagen Granules; Salagen Tab.

Latest Information Update: 04 Apr 2019

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator MGI Pharma
  • Developer ADVANZ PHARMA; Eisai Co Ltd; Kissei Pharmaceutical
  • Class Alkaloids; Antiglaucomas; Furans; Imidazoles; Miotics; Small molecules
  • Mechanism of Action Muscarinic receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Xerostomia

Most Recent Events

  • 01 Apr 2019 ADVANZ Pharma acquires global rights of pilocarpine from Eisai
  • 17 Jul 2017 Merus Labs has been acquired and merged into Norgine
  • 22 May 2015 Merus Labs enters into an agreement with Novartis Pharma for manufacturing and commercialisation of pilocarpine in Europe
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top